Following on from an interim report published by the Medicines and Healthcare products Regulatory Authority (MHRA) on 5 April into the adverse incidents which occured on 13 March during the clinical trial of TGN1412, a final report has been issued on the matter.
Home
About us
Contact us
Library
Login
Print friendly page